These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35074971)

  • 1. Comparison of circulating DNA in malignant neoplasia from diverse locations: Investigating a diagnostic role.
    Kumari S; Mishra S; Husain N; Verma T; Tiwari V; Kaif M; Agarwal A; Rastogi M; Shukla S; Sonkar AA
    Indian J Pathol Microbiol; 2022; 65(1):93-99. PubMed ID: 35074971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of Circulating Free DNA as a Diagnostic Marker in Gall Bladder Cancer.
    Kumari S; Tewari S; Husain N; Agarwal A; Pandey A; Singhal A; Lohani M
    Pathol Oncol Res; 2017 Jan; 23(1):91-97. PubMed ID: 27475647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Value of Circulating Free DNA Integrity and Global Methylation Status in Gall Bladder Carcinoma.
    Kumari S; Husain N; Agarwal A; Neyaz A; Gupta S; Chaturvedi A; Lohani M; Sonkar AA
    Pathol Oncol Res; 2019 Jul; 25(3):925-936. PubMed ID: 29376201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Plasma Circulating Cell-Free DNA Could Be a Potential Marker for Oral Cancer.
    Lin LH; Chang KW; Kao SY; Cheng HW; Liu CJ
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30352977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of plasma cell-free DNA levels in dogs with various tumors.
    Tagawa M; Shimbo G; Inokuma H; Miyahara K
    J Vet Diagn Invest; 2019 Nov; 31(6):836-843. PubMed ID: 31585514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating free DNA as a marker of response to chemoradiation in locally advanced head and neck squamous cell carcinoma.
    Verma T; Kumari S; Mishra S; Rastogi M; Tiwari V; Agarwal GR; Anand N; Husain N
    Indian J Pathol Microbiol; 2020; 63(4):521-526. PubMed ID: 33154299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Utility of Next-Generation Sequencing in Circulating Free DNA and a Comparison With Matched Tissue in Gallbladder Carcinoma.
    Mishra S; Srivastava P; Pandey A; Shukla S; Agarwal A; Husain N
    Lab Invest; 2024 Feb; 104(2):100301. PubMed ID: 38092180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can quantifying free-circulating DNA be a diagnostic and prognostic marker in oral epithelial dysplasia and oral squamous cell carcinoma?
    Shukla D; Kale AD; Hallikerimath S; Yerramalla V; Subbiah V
    J Oral Maxillofac Surg; 2013 Feb; 71(2):414-8. PubMed ID: 22749518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal piRNA profiling revealed unique circulating piRNA signatures of cholangiocarcinoma and gallbladder carcinoma.
    Gu X; Wang C; Deng H; Qing C; Liu R; Liu S; Xue X
    Acta Biochim Biophys Sin (Shanghai); 2020 May; 52(5):475-484. PubMed ID: 32369104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant Telomere Length in Circulating Cell-Free DNA as Possible Blood Biomarker with High Diagnostic Performance in Endometrial Cancer.
    Benati M; Montagnana M; Danese E; Mazzon M; Paviati E; Garzon S; Laganà AS; Casarin J; Giudici S; Raffaelli R; Ghezzi F; Franchi M; Lippi G
    Pathol Oncol Res; 2020 Oct; 26(4):2281-2289. PubMed ID: 32462419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
    Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
    Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can cell-free DNA (cfDNA) in pleural lavage serve as a predictive and prognostic biomarker among surgically treated Stage I-III a nonsmall cell lung cancer (NSCLC)? A pilot study.
    Saikia J; Malik PS; Kumar S; Jain D; Madan K; Bharati SJ; Deo S; Kumar S
    J Surg Oncol; 2024 Jun; 129(7):1224-1234. PubMed ID: 38436618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-stratified reference intervals unlock the clinical potential of circulating cell-free DNA as a biomarker of poor outcome for healthy individuals and patients with colorectal cancer.
    Ørntoft MW; Jensen SØ; Øgaard N; Henriksen TV; Ferm L; Christensen IJ; Reinert T; Larsen OH; Nielsen HJ; Andersen CL
    Int J Cancer; 2021 Apr; 148(7):1665-1675. PubMed ID: 33320961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of survivin mRNA in gallbladder cancer: a diagnostic and prognostic marker?
    Nigam J; Chandra A; Kazmi HR; Parmar D; Singh D; Gupta V; M N
    Tumour Biol; 2014 Sep; 35(9):9241-6. PubMed ID: 24935470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular profiling and utility of cell-free DNA in nonsmall carcinoma of the lung: Study in a tertiary care hospital.
    Ghosh M; Mukhopadhyay M; Das C; Chatterjee S; Naskar BG
    J Cancer Res Ther; 2021; 17(6):1389-1396. PubMed ID: 34916369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Cell-Free DNA Levels Could Predict Oncological Outcomes of Patients Undergoing Esophagectomy for Esophageal Squamous Cell Carcinoma.
    Hsieh CC; Hsu HS; Chang SC; Chen YJ
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-free Circulating Tumor DNA Variant Allele Frequency Associates with Survival in Metastatic Cancer.
    Pairawan S; Hess KR; Janku F; Sanchez NS; Mills Shaw KR; Eng C; Damodaran S; Javle M; Kaseb AO; Hong DS; Subbiah V; Fu S; Fogelman DR; Raymond VM; Lanman RB; Meric-Bernstam F
    Clin Cancer Res; 2020 Apr; 26(8):1924-1931. PubMed ID: 31852833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and Prognostic Value of Circulating DNA Fragments in Glioblastoma Multiforme Patients.
    Jarmuzek P; Wawrzyniak-Gramacka E; Morawin B; Tylutka A; Zembron-Lacny A
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of circulating cell-free DNA levels for hepatocellular carcinoma.
    Yan L; Chen Y; Zhou J; Zhao H; Zhang H; Wang G
    Int J Infect Dis; 2018 Feb; 67():92-97. PubMed ID: 29229500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating free DNA integrity index and promoter methylation of tumor suppressor gene P16, DAPK and RASSF1A as a biomarker for oropharyngeal squamous cell carcinoma.
    Kumari S; Mishra S; Anand N; Hadi R; Rastogi M; Husain N
    Pathol Res Pract; 2023 Jun; 246():154489. PubMed ID: 37150134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.